The mutated KRAS G12D and G12V have been reported as recurrent neoantigens in CRC, and this supports the hypothesis about the role of immune-mediated clonal selection in the above patients (20), which deserves further studies to be definitely addressed. The gene discussed is KRAS; the disease is colorectal carcinoma.